# ATORVASTATIN CALCIUM
> **ANDA209912** · Abbreviated New Drug Application (Generic) · Sponsor: GRAVITI PHARMS · Approved 2018-06-18
## Drug
- **FDA Application Number:** ANDA209912
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ATORVASTATIN CALCIUM
- **Generic name:** ATORVASTATIN CALCIUM, FILM COATED
- **Active ingredients:** ATORVASTATIN CALCIUM
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** GRAVITI PHARMS
- **Manufacturer:** Rising Pharma Holdings, Inc.
- **First approval:** 2018-06-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209912)
---
*AI Analytics · CC0 1.0*